LIVN - LivaNova PLC

63.84
-0.860   -1.347%

Share volume: 509,143
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$64.70
-0.86
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 14%
Dept financing 18%
Liquidity 17%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-9.15%
1 Month
-2.89%
3 Months
1.87%
6 Months
9.47%
1 Year
62.98%
2 Year
18.35%
Key data
Stock price
$63.84
P/E Ratio 
0.00
DAY RANGE
$62.27 - $64.03
EPS 
-$4.45
52 WEEK RANGE
$32.48 - $71.92
52 WEEK CHANGE
$72.45
MARKET CAP 
3.360 B
YIELD 
N/A
SHARES OUTSTANDING 
54.690 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.92
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,094,432
AVERAGE 30 VOLUME 
$926,335
Company detail
CEO: Damien McDonald
Region: US
Website: livanova.com
Employees: 2,900
IPO year: 2015
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

LivaNova PLC designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The company has a research collaboration with Verily to capture clinical biomarkers of depression.

Recent news